文献速递临床试验与 GCP基础与转化研究

TORC1抑制增强老年人免疫功能并减少感染

TORC1 inhibition enhances immune function and reduces infections in the elderly.
PubMed 文献 · Sci Transl Med · 2018-01-01

这项2a期随机安慰剂对照临床试验纳入264名老年人,给予低剂量催化型(BEZ235)联合变构型(RAD001)mTOR抑制剂选择性抑制TORC1共6周。治疗安全,且与用药后一年内老年人报告的感染率显著下降相关(P=0.001),并观察到抗病毒基因表达上调及流感疫苗反应改善。

要点

  • 低剂量BEZ235联合RAD001选择性抑制TORC1在老年人中安全。
  • 治疗组用药后一年内感染率显著下降(P=0.001)。
  • 治疗组抗病毒基因表达上调且流感疫苗反应改善。

核心结论

  • 选择性TORC1抑制有潜力改善老年人免疫功能并减少感染。

研究设计与样本

  • 2a期随机安慰剂对照临床试验,264名老年人接受研究药物6周。

主要发现

  • 低剂量催化型(BEZ235)联合变构型(RAD001)mTOR抑制剂选择性抑制TORC1下游是安全的。
  • 治疗组用药后一年内老年人报告的感染率显著下降(P=0.001)。
  • 治疗组观察到抗病毒基因表达上调及流感疫苗接种反应改善。

关键数值与推荐

  • 感染率下降的显著性为P=0.001,对象为用药后一年内老年人报告的感染。

临床怎么用

  • 低剂量选择性TORC1抑制可能作为改善老年人免疫功能和减少感染的干预策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inhibition of the mechanistic target of rapamycin (mTOR) protein kinase extends life span and ameliorates aging-related pathologies including declining immune function in model organisms. The objective of this phase 2a randomized, placebo-controlled clinical trial was to determine whether low-dose mTOR inhibitor therapy enhanced immune function and decreased infection rates in 264 elderly subjects given the study drugs for 6 weeks. A low-dose combination of a catalytic (BEZ235) plus an allosteric (RAD001) mTOR inhibitor that selectively inhibits target of rapamycin complex 1 (TORC1) downstream of mTOR was safe and was associated with a significant (P = 0.001) decrease in the rate of infections reported by elderly subjects for a year after study drug initiation. In addition, we observed an up-regulation of antiviral gene expression and an improvement in the response to influenza vaccination in this treatment group. Thus, selective TORC1 inhibition has the potential to improve immune function and reduce infections in the elderly.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Mannick JB, Morris M, Hockey HP, et al. TORC1 inhibition enhances immune function and reduces infections in the elderly. Sci Transl Med. 2018. PMID: 29997249. doi:10.1126/scitranslmed.aaq1564

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。